103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB1282 Introduced , by Rep. Daniel Didech SYNOPSIS AS INTRODUCED: 410 ILCS 620/17.3 new Amends the Illinois Food, Drug and Cosmetic Act. Provides that, beginning January 1, 2025, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains specified intentionally added ingredients. Provides an exception to the prohibition. Contains other provisions. LRB103 05003 CPF 50015 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB1282 Introduced , by Rep. Daniel Didech SYNOPSIS AS INTRODUCED: 410 ILCS 620/17.3 new 410 ILCS 620/17.3 new Amends the Illinois Food, Drug and Cosmetic Act. Provides that, beginning January 1, 2025, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains specified intentionally added ingredients. Provides an exception to the prohibition. Contains other provisions. LRB103 05003 CPF 50015 b LRB103 05003 CPF 50015 b A BILL FOR
103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB1282 Introduced , by Rep. Daniel Didech SYNOPSIS AS INTRODUCED:
410 ILCS 620/17.3 new 410 ILCS 620/17.3 new
410 ILCS 620/17.3 new
Amends the Illinois Food, Drug and Cosmetic Act. Provides that, beginning January 1, 2025, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains specified intentionally added ingredients. Provides an exception to the prohibition. Contains other provisions.
LRB103 05003 CPF 50015 b LRB103 05003 CPF 50015 b
LRB103 05003 CPF 50015 b
A BILL FOR
HB1282LRB103 05003 CPF 50015 b HB1282 LRB103 05003 CPF 50015 b
HB1282 LRB103 05003 CPF 50015 b
1 AN ACT concerning health.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Illinois Food, Drug and Cosmetic Act is
5 amended by adding Section 17.3 as follows:
6 (410 ILCS 620/17.3 new)
7 Sec. 17.3. Cosmetic safety.
8 (a) It is the intent of the General Assembly to prohibit
9 the presence of intentionally added ingredients in cosmetics,
10 consistent with the European Union's prohibition on the
11 presence of intentionally added ingredients in cosmetics.
12 (b) In this Section, "ingredient" means any component of a
13 cosmetic product as that term is defined under 21 CFR 700.3.
14 (c) Beginning January 1, 2025, no person or entity shall
15 manufacture, sell, deliver, hold, or offer for sale in
16 commerce any cosmetic product that contains any of the
17 following intentionally added ingredients:
18 (1) Dibutyl phthalate (CAS no. 84-74-2).
19 (2) Diethylhexyl phthalate (CAS no. 117-81-7).
20 (3) Formaldehyde (CAS no. 50-00-0).
21 (4) Paraformaldehyde (CAS no. 30525-89-4).
22 (5) Methylene glycol (CAS no. 463-57-0).
23 (6) Quaternium-15 (CAS no. 51229-78-8).
103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB1282 Introduced , by Rep. Daniel Didech SYNOPSIS AS INTRODUCED:
410 ILCS 620/17.3 new 410 ILCS 620/17.3 new
410 ILCS 620/17.3 new
Amends the Illinois Food, Drug and Cosmetic Act. Provides that, beginning January 1, 2025, no person or entity shall manufacture, sell, deliver, hold, or offer for sale in commerce any cosmetic product that contains specified intentionally added ingredients. Provides an exception to the prohibition. Contains other provisions.
LRB103 05003 CPF 50015 b LRB103 05003 CPF 50015 b
LRB103 05003 CPF 50015 b
A BILL FOR
410 ILCS 620/17.3 new
LRB103 05003 CPF 50015 b
HB1282 LRB103 05003 CPF 50015 b
HB1282- 2 -LRB103 05003 CPF 50015 b HB1282 - 2 - LRB103 05003 CPF 50015 b
HB1282 - 2 - LRB103 05003 CPF 50015 b
1 (7) Mercury (CAS no. 7439-97-6).
2 (8) Isobutylparaben (CAS no. 4247-02-3).
3 (9) Isopropylparaben (CAS no. 4191-73-5).
4 (10) m-Phenylenediamine and its salts (CAS no.
5 108-45-2).
6 (11) o-Phenylenediamine and its salts (CAS no.
7 95-54-5).
8 (12) The following per- and polyfluoroalkyl substances
9 (PFAS) and their salts:
10 (A) Perfluorooctane sulfonate (PFOS) or
11 heptadecafluorooctane-1-sulfonic acid (CAS no.
12 1763-23-1).
13 (B) Potassium perfluorooctanesulfonate or
14 potassium heptadecafluorooctane-1-sulfonate (CAS no.
15 2795-39-3).
16 (C) Diethanolamine perfluorooctane sulfonate (CAS
17 70225-14-8).
18 (D) Ammonium perfluorooctane sulfonate or ammonium
19 heptadecafluorooctanesulfonate (CAS 29081-56-9).
20 (E) Lithium perfluorooctane sulfonate or lithium
21 heptadecafluorooctanesulfonate (CAS 29457-72-5).
22 (F) Perfluorooctanoic acid (PFOA) (CAS no.
23 335-67-1).
24 (G) Ammonium pentadecafluorooctanoate (CAS no.
25 3825-26-1).
26 (H) Nonadecafluorodecanoic acid (CAS no.
HB1282 - 2 - LRB103 05003 CPF 50015 b
HB1282- 3 -LRB103 05003 CPF 50015 b HB1282 - 3 - LRB103 05003 CPF 50015 b
HB1282 - 3 - LRB103 05003 CPF 50015 b
1 355-76-2).
2 (I) Ammonium nonadecafluorodecanoate (CAS no.
3 3108-42-7).
4 (J) Sodium nonadecafluorodecanoate (CAS no.
5 3830-45-3).
6 (K) Perfluorononanoic acid (PFNA) (CAS no.
7 375-95-1).
8 (L) Sodium heptadecafluorononanoate (CAS no.
9 21049-39-8).
10 (M) Ammonium perfluorononanoate (CAS no.
11 4149-60-4).
12 (d) A cosmetic product is not in violation of this Section
13 if:
14 (1) the cosmetic product is made through manufacturing
15 processes that are intended to comply with this Section;
16 (2) the cosmetic product contains a technically
17 unavoidable trace quantity of an ingredient listed in
18 subsection (c); and
19 (3) the trace quantity stems from impurities of
20 natural or synthetic ingredients, the manufacturing
21 process, storage, or migration from packaging.
HB1282 - 3 - LRB103 05003 CPF 50015 b